Abbott gains approval in India for glucose monitoring system

India has the third highest population of obesity, trailing only the United States and China. Nutrition, lifestyle and demographic transitions in India have led to a decline in overall health and a rise in diseases such as diabetes.

To provide tools to better manage diabetes, Abbott has launched the FreeStyle Libre Pro Flash Glucose Monitoring System in India-a transformative new glucose monitoring tool that fundamentally changes how doctors treat people with diabetes. With this tool, doctors can get the comprehensive glucose data they need to make more informed treatment decisions. They can personalize their patient's diabetes treatment plans, allowing people to better manage their disease.

According to the International Diabetes Federation, India today has a diabetes population of 65.1 million compared to 50.8 million in 20103. A recent survey conducted by the Association of Physicians of India (API) and sponsored by Abbott4 showed that 90 percent of people surveyed with uncontrolled diabetes HbA1c level higher than 7 percent in India continue to believe that they have control over their glucose levels, despite facts suggesting otherwise.

"India now carries 20 percent of the global burden of diabetes," said Robert Ford, senior vice president, Diabetes Care, Abbott. "There is an immense need for people in India to better manage their diabetes, enabling them to live healthier lives. Abbott's FreeStyle Libre Pro System is designed to empower doctors in India to help their patients through rich data and actionable insights."